Ranolazine dihydrochloride

• 产品号: R6152
• CAS号: 95635-56-6
• 分子式: C24H35Cl2N3O4
• 分子量: 500.4584
• 纯 度: ≥98% (HPLC)

产品别名

• 标题: Ranolazine dihydrochloride
• IUPAC标准名: N-(2,6-dimethylphenyl)-2-{4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl}acetamide dihydrochloride
• IUPAC传统名: ranolazine dihydrochloride
• 别名: (±) -4-[2-Hydroxy-3-(o-methoxyphenoxy)propyl]-1-piperazineaceto-2′,6′-xylidide dihydrochloride; N-(2,6-Dimethylphenyl)-4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]-1-piperazineacetamide dihydrochloride

产品登记号

• MDL号: MFCD03788770
• PubChem SID: 24278795
• CAS号: 95635-56-6

产品性质

• Empirical Formula (Hill Notation): C24H33N3O4 · 2HCl
• 纯度: ≥98% (HPLC)
• 外观: white to beige powder
• 熔点: 222-229.5 °C(lit.)
• 溶解度: H2O: soluble ≥10 mg/mL
• 个人保护装置: Eyeshields, Gloves, type N95 (US), type P1 (EN143) respirator filter
• 德国WGK号: 3

产品详细信息

详细说明 (English)

Biochem/physiol Actions
pFOX (partial fatty acid oxidation) inhibitor, a new class of anti-anginal drugs, which inhibit fatty acid beta-oxidation and activates pyruvate dehydrogenase, thereby diverting the heart′s energy source from lipids to glucose, which requires less oxygen and helps maintain myocardiac function at times of ischemia

详细说明 (简体中文)

Biochem/physiol Actions
pFOX (partial fatty acid oxidation) inhibitor, a new class of anti-anginal drugs, which inhibit fatty acid beta-oxidation and activates pyruvate dehydrogenase, thereby diverting the heart′s energy source from lipids to glucose, which requires less oxygen and helps maintain myocardiac function at times of ischemia